MTD on a Drug Test: What It Means
MTD on a drug test stands for methadone, a synthetic opioid used to treat opioid use disorder and severe pain. On a multi-panel urine cup or dip card, the MTD line shows whether methadone or its metabolite is present above the test's cutoff concentration.
If you buy, stock or administer screening devices, this one abbreviation affects which panel you order and how you read and document results. It also affects when you send a specimen to a lab for confirmation.
What Does MTD Stand For on a Drug Screen?
On rapid screening devices, MTD is the standard label for the methadone test line. It is one of several short codes printed beside each strip. Related abbreviations on the same device include:
- MOP or MOR: morphine and opiates
- OXY: oxycodone
- BUP: buprenorphine
- MET or mAMP: methamphetamine
Searches for 'MTD meaning' can return unrelated results, such as 'month to date' in accounting. In drug testing, MTD means methadone. If a lab report or custom form uses MTD differently, check the legend or ask the issuing lab.
Why Methadone Gets Its Own Line
Methadone does not reliably trigger the standard opiate test line. That line is designed to detect morphine, codeine and related compounds. A person taking only methadone can therefore screen negative for opiates and still be positive for methadone. Programs that need to verify methadone use or confirm adherence need a dedicated MTD line.
Methadone is also outside the standard federal workplace panel. The DOT 5-panel does not include it, and the HHS opioid category covers codeine, morphine, hydrocodone, hydromorphone, oxycodone and oxymorphone. Employers testing under their own policy, as well as treatment programs, courts and probation offices, may add MTD to an expanded panel.
How the MTD Line Works
Most urine devices use an immunoassay. The strip reacts to methadone or its main metabolite, EDDP, once the concentration passes the cutoff. Cutoffs vary by manufacturer, and 300 ng/mL is common for methadone strips. Always confirm the figure in the package insert for the lot you are using.
- One line visible (control only): a non-negative or presumptive positive result for methadone.
- Two lines (control and MTD): negative, meaning no methadone was detected at or above the cutoff.
- No control line: an invalid test. Repeat it with a new device.
These are screening results. A presumptive positive is not a final finding and should not drive an adverse decision by itself.
MTD Result Decision Guide
| Situation | What the MTD line suggests | Recommended next step |
|---|---|---|
| Patient enrolled in an opioid treatment program | A positive is expected | Compare against dosing records. A negative may signal missed doses or diversion, so follow program protocol. |
| Pre-employment or random test, no disclosed prescription | Presumptive positive | Send for lab confirmation, then route through a Medical Review Officer (MRO) or your documented policy. |
| Court or probation screen | Presumptive positive | Confirm by lab before any violation. Verify any prescription or treatment enrollment. |
| Positive MTD with a negative opiate line | Consistent with methadone-only use | Do not treat as an error. The opiate line is not designed to detect methadone. |
| Unexpected positive with a reported medication history | Possible cross-reactivity | Lab confirmation by GC-MS or LC-MS/MS. |
False Positives and Detection Windows
Immunoassays can cross-react with other compounds. Medications reported to cause false-positive methadone screens include quetiapine, diphenhydramine, doxylamine, verapamil and some phenothiazines. This is the main reason confirmation testing matters. Lab-based mass spectrometry separates methadone and EDDP from look-alike compounds.
Methadone is generally detectable in urine for a few days after the last dose. The window is longer with chronic, high-dose use and varies with metabolism, urine pH and hydration. Do not promise a fixed window to staff or clients.
Buying Checklist for MTD-Capable Tests
- Confirm the panel includes an MTD line, and check whether it is labeled MTD or listed as methadone.
- Check the methadone cutoff, and whether it targets methadone or EDDP, in the package insert.
- Match the panel to your authority: DOT-regulated testing cannot be swapped for an expanded non-DOT panel.
- Decide whether you need temperature strips and adulterant checks.
- Set a written policy for non-negative results, including lab confirmation.
- Document lot numbers and expiration dates, and train staff on reading and recording results.
- Plan for prescription disclosure and MRO or clinical review.
Choosing the Right Format
Integrated cups collect and test in one step, which suits high-volume clinics and intake settings. Browse our drug test cups and check which panels include the methadone line. If you need help matching a panel to your program, policy or state requirements, contact American Screening Corp. We supply clinics, hospitals, treatment centers, courts, labs, staffing firms and employers from Shreveport, Louisiana.
Frequently Asked Questions
What is MTD on a drug test?
MTD is the abbreviation for methadone. It labels the test line that screens for methadone or its metabolite, EDDP, in urine.
Does MTD on a drug screen mean someone is abusing drugs?
No. Methadone is a legitimate medication for opioid use disorder and pain management. A positive shows presence only, not misuse, so verify prescription or treatment status before drawing conclusions.
Is MTD included on a standard 5-panel or DOT test?
No. Methadone is not part of the DOT 5-panel or the standard federal opioid category. It appears on expanded or treatment-oriented panels.
Can an MTD result be wrong?
Yes. Some medications can cross-react with immunoassay strips and produce a false presumptive positive. Confirmation by GC-MS or LC-MS/MS gives a definitive result.
Sources
- SAMHSA: Methadone
- MedlinePlus (NIH): Methadone
- eCFR: 49 CFR Part 40, DOT Workplace Drug and Alcohol Testing Procedures
This article is general information, not legal or medical advice.
